Frontiers | Therapeutic Strategies in EGFR Mutant Lung Cancer

Therapeutic Strategies in EGFR Mutant Lung Cancer

36k
Total downloads
123k
Total views and downloads

Download PDF Download EPUB

Articles

SYSTEMATIC REVIEW

Published on 01 Aug 2022

An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer

Yuexiao Qi
Xiaojun Xia
Lihua Shao
Liyun Guo
Yumei Dong
Jinhui Tian
Lijun Xu
Ruijun Niu
Shihong Wei

doi 10.3389/fonc.2022.616546

3,184 views
5 citations

ORIGINAL RESEARCH

Published on 14 Dec 2021

Modelled Economic Analysis for Dacomitinib–A Cost Effectiveness Analysis in Treating Patients With EGFR-Mutation-Positive Non-Small Cell Lung Cancer in China

Yong-feng Yu
Luan Luan
Fan-fan Zhu
Peng Dong
Li-Heng Ma
Lan-ting Li
Lan Gao
Shun Lu

doi 10.3389/fonc.2021.564234

2,130 views
4 citations

ORIGINAL RESEARCH

Published on 22 Jul 2021

c-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma

Weili Min
Chenyang He
Shuqun Zhang
Yang Zhao

doi 10.3389/fonc.2021.602900

2,061 views
4 citations

REVIEW

Published on 25 May 2021

Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies

Kenneth K. W. To
Winnie Fong
William C. S. Cho

doi 10.3389/fonc.2021.635007

33,296 views
97 citations

SYSTEMATIC REVIEW

Published on 24 May 2021

Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer

Xiaoshun Shi
Xiaoying Dong
Jianxue Zhai
Xiguang Liu
Di Lu
Zhen Ni
Hua Wu
Kaican Cai

doi 10.3389/fonc.2021.608608

1,993 views
6 citations

ORIGINAL RESEARCH

Published on 06 May 2021

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer

Maria Gabriela O. Fernandes
Catarina Sousa
Maria Jacob
Leonor Almeida
Vanessa Santos
David Araújo
Hélder Novais Bastos
Adriana Magalhães
Luís Cirnes
3 more
Venceslau Hespanhol

doi 10.3389/fonc.2021.602924

2,595 views
5 citations

ORIGINAL RESEARCH

Published on 29 Apr 2021

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

Krittiya Korphaisarn
Pongwut Danchaivijitr
Thanyanan Reungwetwattana
Busayamas Chewaskulyong
Luangyot Thongthieang
Jarin Chindaprasirt
Kunlatida Maneenil
Chirawadee Sathitruangsak
Chanida Vinayanuwattikun

doi 10.3389/fonc.2021.572740

2,282 views
6 citations

CASE REPORT

Published on 26 Apr 2021

Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review

Alessandro Leonetti
Roberta Minari
Giulia Mazzaschi
Letizia Gnetti
Silvia La Monica
Roberta Alfieri
Nicoletta Campanini
Michela Verzè
Andrea Olivani
1 more
Marcello Tiseo

doi 10.3389/fonc.2021.642190

6,868 views
28 citations

ORIGINAL RESEARCH

Published on 19 Apr 2021

Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma

Fangqiu Fu
Zhexu Wen
Zhendong Gao
Yue Zhao
Yuan Li
Yang Zhang
Haiquan Chen

doi 10.3389/fonc.2021.622723

1,443 views
2 citations

SYSTEMATIC REVIEW

Published on 13 Apr 2021

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Qiang Wu
Wuxia Luo
Wen Li
Ting Wang
Lin Huang
Feng Xu

doi 10.3389/fonc.2021.598265

5,531 views
32 citations

CASE REPORT

Published on 07 Apr 2021

Lung Adenocarcinoma Patient Harboring EGFR-KDD Achieve Durable Response to Afatinib: A Case Report and Literature Review

Lingling Zhao
Zhen Wang
Haiwei Du
Songan Chen
Pingli Wang

doi 10.3389/fonc.2021.605853

1,874 views
6 citations

ORIGINAL RESEARCH

Published on 30 Mar 2021

The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy

Alex Friedlaender
Petros Tsantoulis
Mathieu Chevallier
Claudio De Vito
Alfredo Addeo

doi 10.3389/fonc.2021.644472

7,913 views
22 citations

Share on

Frontiers in Oncology

Thoracic Oncology

Impact

123kTopic views
85kArticle views
36kArticle downloads

View impact

Submit your idea

Articles

An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer

Modelled Economic Analysis for Dacomitinib–A Cost Effectiveness Analysis in Treating Patients With EGFR-Mutation-Positive Non-Small Cell Lung Cancer in China

c-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma

Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies

Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review

Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Lung Adenocarcinoma Patient Harboring EGFR-KDD Achieve Durable Response to Afatinib: A Case Report and Literature Review

The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy

Frontiers in Oncology

Impact